We are devoted to strengthening emerging pharmaceutical markets. To this end, we commit to upholding essential principles in all of our dealings with clients. Our Client Charter is our promise to you that ...
Our Quality Edge is how we blend Empathy, Reliability and Responsiveness to deliver exceptional service to all our clients.
We Partner with Clients to execute Outcomes Research in emerging markets.
We develop results-driven market access solutions for clients in emerging markets.
We are devoted to strengthening emerging pharmaceutical markets.
Market Access Solutions
Innovative Access Strategies
Our Quality Edge
It's been a gggrrreat year! Thank-you! carapinha.com/its-been-a-ggg… pic.twitter.com/7stzH9AVRG
About 2 weeks ago from Carapinha & Company's Twitter
It's been a gggrrreat year! Thank-you! carapinha.com/its-been-a-ggg… pic.twitter.com/aBvhR5keoY
Did you know, since 2007 we have built stronger pharmaceutical markets. Don't be left behind, see our infographic on how we get business done! carapinha.com/link/infograph… pic.twitter.com/2TiC3ZhPGM
GSK, Johnson & Johnson, Sanofi, Merck and Novartis are top 5 investors in global health products, says report phrmaccess.com/x/vk pic.twitter.com/XWTMsevnY3
About 3 weeks ago from Carapinha & Company's Twitter
Pharma increasingly turning to artificial intelligence, but it’s not a silver bullet. phrmaccess.com/x/vl pic.twitter.com/6YcInE3nQK
“Building the Bioeconomy” highlights linkages between economic and social benefits of biotechnology innovation phrmaccess.com/x/vm pic.twitter.com/T5UHRvgAdb
USA: how Bernie Sanders plans to reduce medicine prices phrmaccess.com/x/vg pic.twitter.com/FUYxUBq3td
Pharma companies could do more to improve access to medicines, says report phrmaccess.com/x/vi pic.twitter.com/zrKuv9o6jw
Canada: will PMPRB changes threaten the availability of new medicines for patients? phrmaccess.com/x/v7 pic.twitter.com/RSad86VuHo
Last month from Carapinha & Company's Twitter
Value-based pricing is important but so is affordability, says ISPOR Panel. phrmaccess.com/x/v8 pic.twitter.com/LdkL54zDw6
Did you know, since 2007 we have built stronger pharmaceutical markets. Don't be left behind, see our infographic on how we get business done! carapinha.com/link/infograph… pic.twitter.com/8Cm2oqu4qc
USA: Blue Cross Blue Shield study, 17% of branded medicines account for 79% of medicine spending phrmaccess.com/x/v2 pic.twitter.com/kMyMAzmQyi
USA corporations (Walmart, Home Depot, etc.) are pushing Big Pharma on drug cost disparities phrmaccess.com/x/v6 pic.twitter.com/zn7KpL6LWs
South Africa: DoH trying desperately to attract GPs into providing services under NHI phrmaccess.com/x/uz pic.twitter.com/HTiicMlezr
Pharma welcomes Brexit agreement but raises more questions as politicians clash over details phrmaccess.com/x/v0 pic.twitter.com/xKj1v8tFXf